Page last updated: 2024-11-04

diethylnitrosamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5921
CHEMBL ID164290
CHEBI ID34873
SCHEMBL ID106629
MeSH IDM0006354

Synonyms (93)

Synonym
BIDD:ER0527
CHEBI:34873 ,
1,1-diethyl-2-oxohydrazine
inchi=1/c4h10n2o/c1-3-6(4-2)5-7/h3-4h2,1-2h
NCGC00091350-01
hsdb 4001
brn 1744991
den (mutagen)
ccris 239
einecs 200-226-1
n-ethyl-n-nitroso-ethanamine
rcra waste number u174
diethylnitrosamide
nitrosamine, diethyl-
nsc 132
rcra waste no. u174
n-nitroso-diaethylamine [german]
n-diethylnitrosamine
diaethylnitrosamin [german]
ai3-62031
nitrosodiethylamine
n-nitroso-n,n-diethylamine
diethylnitrosoamine
n,n-diethylnitrosoamine
ndea
DEN ,
dena
55-18-5
ethylamine, n-nitrosodi-
diethylamine, n-nitroso-
nsc-132
wln: onn2&2
diaethylnitrosamin
ethanamine, n-ethyl-n-nitroso-
nsc132
n-ethyl-n-nitrosoethanamine
n,n-diethylnitrosamine
n-nitrosodiethylamine
diethylnitrosamine
n-nitrosodiethylamine, isopac(r)
n-nitrosodiethylamine, analytical standard
n-nitrosodiethylamine, liquid
n-nitrosodiethlamine
n-nitrosodiethylamine, >=99.0% (gc)
D0516
MLS002415760
smr001370919
n-nitrosodiethylamine-d4
CHEMBL164290
n,n-diethylnitrous amide
NCGC00091350-04
NCGC00091350-02
NCGC00091350-03
HMS3039G08
tox21_300533
dtxcid901028
dtxsid2021028 ,
NCGC00258807-01
tox21_201255
NCGC00254309-01
cas-55-18-5
STL220642
3iq78ttx1a ,
unii-3iq78ttx1a
n-nitroso-diaethylamine
FT-0631240
AKOS015903105
n-nitrosodiethylamine [hsdb]
n-nitrosodiethylamine [usp-rs]
n-nitrosodiethylamine [iarc]
n-nitrosodiethylamine [mi]
SCHEMBL106629
n-ethyl-n-nitroso-ethylamine
1,1-diethyl-2-oxohydrazine #
1346603-41-5
n-nitroso-diethylamine 100 microg/ml in methanol
n-nitroso-diethylamine
BCP19136
mfcd00013890
SY053647
F14922
diethyl-nitroso-amine
BS-17234
Q22138388
CS-0128799
n-nitrosodiethyl-d10-amine
diaethylnitrosamin;ndma
n-nitrosodiethylamine 0.1 mg/ml in methanol
n-nitroso-diethylamine 1000 microg/ml in methanol
HY-N7434
EN300-1296529
diethyl(nitroso)amine
Z1255485632

Research Excerpts

Overview

Diethylnitrosamine (DEN) is a well known carcinogen that induces cancers of various organs in mice and rats. In vivo DNA-damaging activities are not usually evident in hematopoietic cells because the short-lived active metabolite is formed mainly in the liver.

ExcerptReferenceRelevance
"Diethylnitrosamine (DEN) is a well-known hepatocarcinogen, and its oral administration causes severe liver damage including cancer. "( 6-Gingerol, a Major Ingredient of Ginger Attenuates
Almatroodi, SA; Almatroudi, A; Almutary, AG; Alrumaihi, F; Alsahli, MA; Anwar, S; Khan, AA; Rahmani, AH, 2021
)
2.06
"Diethylnitrosamine is a well known carcinogen that induces cancers of various organs in mice and rats. "( Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse.
Baghy, K; Egedi, K; Kovalszky, I; Mervai, Z, 2018
)
3.37
"Diethylnitrosamine (DEN) is a genotoxic carcinogen, but in vivo DNA-damaging activities are not usually evident in hematopoietic cells because the short-lived active metabolite is formed mainly in the liver. "( Diethylnitrosamine genotoxicity evaluated in sprague dawley rats using pig-a mutation and reticulocyte micronucleus assays.
Avlasevich, SL; Bemis, JC; Carlson, K; Cottom, J; Dertinger, SD; Labash, C; MacGregor, JT; Phonethepswath, S; Torous, DK, 2014
)
3.29
"Diethylnitrosamine (DEN) is a potent toxic material that can cause necrosis and subsequent fibrosis in the liver. "( Protective Effects of Ethyl Acetate Soluble Fraction of Limonium tetragonum on Diethylnitrosamine-Induced Liver Fibrosis in Rats.
Heo, JD; Jeong, EJ; Kim, NH; Kim, TB; Rho, JR; Yang, MH, 2016
)
2.1
"Diethylnitrosamine (DEN) is a representative chemical carcinogen with the potential to cause tumors in various organs, including the liver, skin, gastrointestinal tract, and respiratory system."( Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G1/S-phase regulatory proteins in rat.
Jang, JJ; Lee, MJ; Li, L; Park, DH; Park, SK; Seo, JN; Shin, JW, 2009
)
2.52
"Diethylnitrosamine (DEN) is a hepatic procarcinogen which is frequently used as an inducer of hepatocellular carcinoma (HCC) in mice. "( Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice.
Aleksic, K; Auer, M; Fischer, M; Geigl, JB; Lackner, C; Otte, M; Schwarz, M; Speicher, MR; Trajanoski, Z; Ulz, P, 2011
)
2.09
"Diethylnitrosamine (DEN) is a well known carcinogenic substance, which induces hepatic carcinoma."( Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats.
Das, N; Ghosh, A; Ghosh, D; Mandal, AK; Sarkar, S; Thakur Choudhury, S, 2012
)
1.33
"Diethylnitrosamine (DEN) is a potent hepatotoxin and hepatocarcinogen in animals and possible in humans. "( Osteopontin is involved in estrogen-mediated protection against diethylnitrosamine-induced liver injury in mice.
Cao, L; Chen, R; Fan, X; Guo, Y; He, C; Liang, B; Zhao, J, 2012
)
2.06
"N-diethylnitrosamine is an important carcinogen used in liver cancer animal models."( Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis.
Alemán-Lazarini, L; Carrasco-Legleu, C; García-Cuellar, C; Hernández-García, S; Pérez-Carreón, J; Salcido-Neyoy, M; Sánchez-Pérez, Y; Villa-Treviño, S, 2005
)
0.89
"Diethylnitrosamine (DEN) is a well-known carcinogenic substance that requires microsomal activation before it can react with DNA to cause mutations and cancer. "( In vivo detection of free radicals induced by diethylnitrosamine in rat liver tissue.
Utsumi, H; Yamada, K; Yamamiya, I, 2006
)
2.03
"Diethylnitrosamine (DEN) is a known carcinogen that can alkylate DNA molecules. "( Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma.
Chan, CY; Chen, X; Kung, HF; Lai, L; Li, D; Lin, MC; Qi, Y; Yew, DT; Yu, F; Yuan, C, 2008
)
2.03
"Diethylnitrosamine (DEN) is a carcinogen that stimulates the development of epidermoid carcinoma in the esophagus of mice."( Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis--experimental model in Wistar female rats.
Boeno, Rda L; Cavazzola, LT; Grossi, RS; Kliemann, LM; Kruel, CD; Melo, LL; Silber, PC, 1999
)
1.02

Effects

The Diethylnitrosamine (DEN) model has an age-related effect. It has an established potential of producing experimental cancer in the esophagus and liver.

ExcerptReferenceRelevance
"The Diethylnitrosamine (DEN) model has an age-related effect."( A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.
Jung, Y; Lee, JI; Lee, WK; Memon, A; Pyao, Y, 2020
)
1.35
"Diethylnitrosamine has an established potential of producing experimental cancer in the esophagus and liver."( Morphine does no promote esophageal carcinogenesis in rats exposed to diethylnitrosamine.
Cerski, CT; Dillenburg, CF; Edelweiss, MI; Kruel, CD; Schier, AS; Silva, TL,
)
1.09
"The Diethylnitrosamine (DEN) model has an age-related effect."( A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.
Jung, Y; Lee, JI; Lee, WK; Memon, A; Pyao, Y, 2020
)
1.35
"Diethylnitrosamine has an established potential of producing experimental cancer in the esophagus and liver."( Morphine does no promote esophageal carcinogenesis in rats exposed to diethylnitrosamine.
Cerski, CT; Dillenburg, CF; Edelweiss, MI; Kruel, CD; Schier, AS; Silva, TL,
)
1.09

Actions

Diethylnitrosamine is known to cause squamous cell carcinoma and adenocarcinoma of the lung in Syrian golden hamsters.

ExcerptReferenceRelevance
"Diethylnitrosamine is known to cause squamous cell carcinoma and adenocarcinoma of the lung in Syrian golden hamsters. "( Effects of diethylnitrosamine on lung neuroendocrine cells.
Linnoila, RI, 1982
)
2.1
"Diethylnitrosamine is known to cause squamous cell carcinoma and adenocarcinoma of the lung in Syrian golden hamsters. "( Lung endocrine-like cells in hamsters treated with diethylnitrosamine: alterations in vivo and in cell culture.
DiAugustine, RP; Linnoila, RI; Nettesheim, P, 1981
)
1.96
"Diethylnitrosamine failed to transform RLC-1 cells with or without tetradecanoylphorbol acetate (TPA) promotion."( 12-O-Tetradecanoylphorbol-13-acetate promotion of carcinogen-treated rat liver endothelial cells.
Higgins, PJ, 1985
)
0.99

Treatment

Diethylnitrosamine (DEN) treatment increases the generation of reactive oxygen species (ROS), apoptosis, necrosis and proliferation in the liver. In rats treated with repeated CCl4 injections, gamma-glutamyl transpeptidase (gamma-GTP)-positive hyperplastic nodules were markedly developed in the 8th week of the experiment.

ExcerptReferenceRelevance
"In diethylnitrosamine (DEN)-treated primary hepatocytes, NAC and Trolox alleviated DNA damage by activating ataxia-telangiectasia mutated (ATM)/ATM and Rad3-related (ATR) for DNA repair whereas SS-31 and Mito-Q aggravated damage by inactivating them."( Contradictory effects of mitochondria- and non-mitochondria-targeted antioxidants on hepatocarcinogenesis by altering DNA repair in mice.
Chen, Y; Fu, J; Qin, W; Wang, B; Wang, H; Xu, A; Yang, Z; Yu, T, 2018
)
0.99
"Diethylnitrosamine-treated male mice were assigned to 4 groups: a casein-based 35% high fat ethanol liquid diet (EtOH), an EtOH diet made with soy protein isolate protein (EtOH/SOY), an EtOH liquid diet supplemented with genistein (EtOH/GEN) and a chow group. "( Diet Supplementation with Soy Protein Isolate, but Not the Isoflavone Genistein, Protects Against Alcohol-Induced Tumor Progression in DEN-Treated Male Mice.
Cleves, MA; Drake, RR; Hennings, L; Jones, EE; Mercer, KE; Pulliam, CF; Ronis, MJJ,
)
1.57
"Diethylnitrosamine (DEN) treatment increases the generation of reactive oxygen species (ROS), apoptosis, necrosis and proliferation in the liver. "( Effect of blueberry pretreatment on diethylnitrosamine-induced oxidative stress and liver injury in rats.
Başaran-Küçükgergin, C; Bingül, İ; Doğru-Abbasoğlu, S; Olgaç, V; Tekkeşin, MS; Uysal, M, 2013
)
2.11
"In diethylnitrosamine (DEN)-treated rats, which were fed a N-2-fluorenylacetamide (FAA)-containing diet and additionally treated with repeated CCl4 injections, gamma-glutamyl transpeptidase (gamma-GTP)-positive hyperplastic nodules were markedly developed in the 8th week of the experiment."( Effects of carbon tetrachloride and azathioprine on diethylnitrosamine and N-2-fluorenylacetamide-induced hyperplastic liver nodule and hepatocellular carcinoma.
Sakata, T, 1984
)
1.03
"Diethylnitrosamine-treated TT mice developed both preneoplastic and neoplastic lesions in the liver."( Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene.
Altavilla, G; Barbanti-Brodano, G; Caputo, A; Corallini, A; Lanfredi, M; Piola, C, 2000
)
1.03
"When diethylnitrosamine treatment was stopped, there was a rapid drop in polymerase beta activity."( Sequential changes in DNA polymerases alpha and beta during diethylnitrosamine-induced carcinogenesis.
Ansley, CM; Craddock, VM, 1979
)
0.96
"Treatment with diethylnitrosamine (DEN) at 6 h or at 24 h had a similar effect to DMN on the wave of DNA replication induced by partial hepatectomy."( Effect of a single treatment with the alkylating carcinogens dimethylnitrosamine, diethylnitrosamine and methyl methanesulphonate, on liver regenerating after partial hepatectomy. II. Alkylation of DNA and inhibition of DNA replication.
Craddock, VM, 1975
)
0.81
"5. Treatment of diethylnitrosamine-injected young immature male Fischer 344 rats at the prenodular phase of hepatic premalignancy with tri-iodothyronine at 0.005 micrograms/kg s.c."( Diethylnitrosamine-induced increase in gamma-glutamyltranspeptidase in rat liver: its association with thyroid hormone deficiency and its reversal by tri-iodothyronine.
Pulga, VB; Sulakhe, SJ; Tran, ST, 1992
)
2.06
"Treatment with diethylnitrosamine induced tracheal papillomas in the Syrian golden hamster. "( Autophagic mechanisms in diethylnitrosamine-induced tracheal papillomas of Syrian golden hamster.
Emura, M; Mohr, U; Wahnschaffe, U, 1987
)
0.93

Toxicity

ExcerptReferenceRelevance
"The LD50 of DMN was determined in groups of mice in the presence of inhibitors of DMN demethylase."( Acute toxicity of dimethylnitrosamine in the presence of inhibitors of DMN demethylase.
Friedman, MA; Sanders, V, 1976
)
0.26
" Although no toxicity-related hepatocyte lesions were found, severe renal toxic tubular lesions and regeneration were evident."( Lack of hepatotoxicity or promotion of enzyme-altered liver foci development in rats treated with harman or norharman.
Hagiwara, A; Ito, N; Kato, T; Kurata, Y; Tanaka, H; Tsuda, H, 1990
)
0.28
" The toxic depletion of hepatocytes and the attendant altered cellular environment are discussed in relation to cell-to-cell interactions and the possible contribution of stromal and extracellular matrix changes to liver regeneration and neoplasia."( Cytotoxicity phase of diethylnitrosamine-induced hepatic neoplasia in medaka.
Hinton, DE; Laurén, DJ; Teh, SJ, 1990
)
0.59
" In this model HQ could be shown to be selectively toxic to GGT-negative cells in the presence of extracellular GSH."( The role of GSH depletion and toxicity in hydroquinone-induced development of enzyme-altered foci.
Högberg, J; Lundberg, I; Rannug, A; Stenius, U; Walles, S; Warholm, M, 1989
)
0.28
" The results demonstrate the unique susceptibility of cells of the Bowman's glands to the toxic effects of NDEA given ip and indicate that nasal tissues of the rat are more susceptible to the necrogenic effects of NDEA than those of the hamster."( Toxic effects of N-nitrosodiethylamine on nasal tissues of Sprague-Dawley rats and golden Syrian hamsters.
Jensen, RK; Sleight, SD, 1987
)
0.27
" Also, ascorbate deficiency significantly decreased the plasma clearance of both nitrosamines though the LD50 of neither were altered by ascorbate nutrition."( The effects of ascorbic acid deficiency and excess on the metabolism and toxicity of N-nitrosodimethylamine and N-nitrosodiethylamine in the guinea pig.
Fong, LY; Ton, CC, 1984
)
0.27
" Recently we have shown that false-positive results can still be obtained due to cytotoxicity when loss of membrane integrity is a late event in toxic cell death relative to the induction of endonucleolytic DNA degradation."( Revalidation of the in vitro alkaline elution/rat hepatocyte assay for DNA damage: improved criteria for assessment of cytotoxicity and genotoxicity and results for 81 compounds.
Barnum, JE; DeLuca, JG; Elia, MC; Harmon, LS; Kraynak, AR; McKelvey, TW; Nichols, WW; Storer, RD, 1996
)
0.29
" We examined the generality of this pattern in livers of rats given a minimally toxic dose of an hepatotoxin and in liver biopsy samples from patients who had taken overdoses of acetaminophen."( Zonal location of compensatory hepatocyte proliferation following chemically induced hepatotoxicity in rats and humans.
Archer, MC; Cameron, RG; Lee, VM,
)
0.13
" Laboratory toxicity testing of single compounds can produce toxicity data specific to that compound for that species but cannot take into account the possible toxic effects of mixtures of compounds."( Environmental complex mixture toxicity assessment.
Boncavage-Hennessey, EM; Brennan, LM; Gardner, HS; Rosencrance, AB; Toussaint, MW; Wolfe, MJ, 1998
)
0.3
" Our data show that NDGA can abrogate the toxic and tumour-promoting effects of Fe-NTA in liver and kidney of mice and can serve as a potent chemopreventive agent to suppress oxidant-induced tissue injury and tumorigenesis."( Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice.
Ansar, S; Athar, M; Iqbal, M, 1999
)
0.3
" blazei exerts a hepatoprotective effect on both liver toxicity and hepatocarcinogenesis process induced by a moderately toxic dose of DEN."( Influence of aqueous extract of Agaricus blazei on rat liver toxicity induced by different doses of diethylnitrosamine.
Barbisan, LF; de Camargo, JL; Eira, AF; Miyamoto, M; Ribeiro, LR; Salvadori, DM; Scolastici, C, 2002
)
0.53
" NDEA was administered ip as a single dose to rats in LD50 or in lower amounts and the animals were sacrificed after 0-48 hr of treatment."( Hepatic and renal oxidative stress in acute toxicity of N-nitrosodiethylamine in rats.
Bansal, AK; Bhatnagar, D; Soni, GL; Trivedi, R, 2000
)
0.31
" The presence of high levels of acetyltransferase may generate toxic compounds that must be eliminated by cellular processes or can lead to cell death, and consequently decrease the mutagenic effect, as can be observed by the comparison of strain TA98DNP6 with the strains TA98 and YG1024."( Evaluation of nitroreductase and acetyltransferase participation in N-nitrosodiethylamine genotoxicity.
Aiub, CA; Felzenszwalb, I; Mazzei, JL; Pinto, LF, 2006
)
0.33
" Our results showed a resistance to the toxic effects of EA since viability and cellular integrity values were significantly higher than control."( Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity.
Alvarez, Mde L; Carnovale, C; Carrillo, MC; Francés, D; Parody, JP; Quiroga, A; Ronco, MT, 2007
)
0.34
" Chromosome stickiness suggests a NDEA toxic effect."( Ability of Allium cepa L. root tips and Tradescantia pallida var. purpurea in N-nitrosodiethylamine genotoxicity and mutagenicity evaluation.
Aiub, CA; de Rainho, CR; Felzenszwalb, I; Kaezer, A, 2010
)
0.36
"These results suggest that n-3 fatty acids could ameliorate the toxic effects of DEN in part by means of its free radical scavenging activity and may be of therapeutic value in the protection of liver against toxic effects of DEN."( Protective effect of omega-3 fatty acids on diethylnitrosamine toxicity in rats.
Atakisi, E; Atakisi, O; Karapehlivan, M; Kart, A; Ozcan, A, 2013
)
0.65
"It is considered that diethylnitrosamine (DENA) is metabolized mostly in the liver with producing highly reactive compounds alkylating cellular macromolecules and causing toxic and carcinogenic effects."( [Increase of general toxic effects and decrease of hepatocarcinogenic effects of diethylnitrosamine administered to mice in conjunction with isopropanol].
Baginskaia, NV; Il'nitskaia, SI; Kaledin, VI; Ovchinnikova, LP; Vasiunina, EA, 2012
)
0.92
" Biochemical marker values and adverse events were evaluated after CT imaging."( Safety and Feasibility of Contrast-Enhanced Computed Tomography with a Nanoparticle Contrast Agent for Evaluation of Diethylnitrosamine-Induced Liver Tumors in a Rat Model.
Jogo, A; Kageyama, K; Kakehashi, A; Miki, Y; Murai, K; Nota, T; Ogawa, S; Sohgawa, E; Yamamoto, A; Yonezawa, H, 2023
)
1.12
"CECT with ExiTron nano 12000 is a safe and feasible method to measure tumors in a rat liver tumor model."( Safety and Feasibility of Contrast-Enhanced Computed Tomography with a Nanoparticle Contrast Agent for Evaluation of Diethylnitrosamine-Induced Liver Tumors in a Rat Model.
Jogo, A; Kageyama, K; Kakehashi, A; Miki, Y; Murai, K; Nota, T; Ogawa, S; Sohgawa, E; Yamamoto, A; Yonezawa, H, 2023
)
1.12

Pharmacokinetics

ExcerptReferenceRelevance
"Pharmacokinetics of drug may be altered by abnormal physiological functions in illness, which will affect its pharmacodynamic efficacy in turn."( Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects.
Cai, D; Feng, L; Jiao, Y; Liu, X; Mao, W; Wang, X; Wang, Y; Zhang, D; Zhang, J; Zhao, X, 2014
)
0.4
"To assess the preventive effects of tetramethylpyrazine (TMPZ) phosphate on hepatocarcinogenesis and its pharmacokinetic differentiations in model mice."( Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects.
Cai, D; Feng, L; Jiao, Y; Liu, X; Mao, W; Wang, X; Wang, Y; Zhang, D; Zhang, J; Zhao, X, 2014
)
0.4
" Pharmacokinetic variations of TMPZ between control and model mice were measured for single oral administration."( Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects.
Cai, D; Feng, L; Jiao, Y; Liu, X; Mao, W; Wang, X; Wang, Y; Zhang, D; Zhang, J; Zhao, X, 2014
)
0.4
" In pharmacokinetic study, values of AUC and Tmax of TMPZ became significantly greater with increase of doses in both control and model mice, which elucidated the absorption was enhanced and delayed; meanwhile, its elimination was not affected markedly."( Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects.
Cai, D; Feng, L; Jiao, Y; Liu, X; Mao, W; Wang, X; Wang, Y; Zhang, D; Zhang, J; Zhao, X, 2014
)
0.4
" Statistically significant differences were observed between conventional rats and diethylnitrosamine (DEN)-induced HCC rats with respect to pharmacokinetic parameters, including maximum concentration (Cmax), time to reach Cmax (Tmax), half-life (t1/2), area under the concentration-time curve (AUC0-t, AUC0-∞), mean residence time (MRT0-t and MRT0-∞), and oral clearance (CL/F)."( Pharmacokinetics and tissue distribution study of caudatin in normal and diethylnitrosamine-induced hepatocellular carcinoma model rats.
Ding, Y; Peng, Y, 2015
)
0.87
" The study aimed to investigate the pharmacokinetic mechanism of herb-drug interactions between ADI and DOX in a rat model of HCC."( Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma.
Cao, C; Chen, S; Huang, J; Li, Y; Liu, C; Liu, T; Lu, Y; Pan, J; Sun, J; Wang, Y; Zhang, S; Zhu, X, 2021
)
0.84
" The HCC rats were pretreated with ADI (10 mL/kg, intraperitoneal injection) for 14 consecutive days prior to administration of DOX (7 mg/kg, intravenous injection) to investigate pharmacokinetic interactions."( Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma.
Cao, C; Chen, S; Huang, J; Li, Y; Liu, C; Liu, T; Lu, Y; Pan, J; Sun, J; Wang, Y; Zhang, S; Zhu, X, 2021
)
0.84

Compound-Compound Interactions

ExcerptReferenceRelevance
" The aim of the present study was to assess the carcinogenicity of daminozide alone and in combination with 1,1-dimethylhydrazine (UDMH), its major contaminant, in a novel medium-term bioassay in Fischer 344 rats, the DEN-PH model."( Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
Cabral, R; Hakoi, K; Hasegawa, R; Hoshiya, T; Ito, N,
)
0.13
" In the present study, differences between species, strain and sexes in susceptibility to radiation or radiation combined with DEN were examined."( Species, strain and sex differences in susceptibility to gamma radiation combined with diethylnitrosamine.
Jang, JJ; Kang, SK; Kim, TH; Lee, YS; Myong, NH,
)
0.35
" Polyen antibiotics combined with DMSO also demonstrated antineoplastic activity at the animals treated with carcinogenic agent--diethyl nitrosoamine (DENA)."( [Radioprotective and antineoplastic activity of polyene antibiotics combined with dimethyl sulfoxide].
Aliev, DI; Ibragimova, VKh, 2002
)
0.31

Bioavailability

ExcerptReferenceRelevance
" After cutaneous application NDELA was rapidly absorbed through the skin, and the absolute bioavailability was calculated to be 27% from blood data, and to be 32% (NDELA + ECMN) from urine data."( Kinetics and bioavailability of N-nitrosodiethanolamine after intravenous and cutaneous administration to rats.
Airoldi, L; Bonati, M; Bonfanti, M; Fanelli, R; Macri, A, 1984
)
0.27
" Pharmacokinetic analysis revealed that GA–NC displayed a characteristic sustained release profile with\ 4-fold increase in bioavailability in normal and HCC-induced rats."( Improving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation
Abd-Rabou, AA; Ahmed, HH; Galal, AF; Mehaya, FM; Shalby, AB, 2018
)
0.48
" Due to poor solubility and low bioavailability SYL lacks satisfactory therapeutic value thus designing a suitable and effective delivery system of SYL can led to improved therapeutic potential."( Dextrose modified bilosomes for peroral delivery: improved therapeutic potential and stability of silymarin in diethylnitrosamine-induced hepatic carcinoma in rats.
Dwivedi, M; Parashar, P; Rana, P; Saraf, SA, 2019
)
0.73
" However, the bioavailability of ABZ is very poor."( Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression.
Amin, NA; Batiha, GE; El-Ahwany, E; El-Rous, MA; Elagamy, HI; Elewa, YHA; Elsergany, RN; Girgis, S; Gobba, NA; Hafez, AM; Kaddah, MMY; Kamal, I; Khodir, AE; Mahmoud, MH; Mourad, AAE; Nasr, M; Saad, AS; Saber, S; Shata, A, 2021
)
0.84
" As a competitor of SHBG-androgen binding, EE2 could bind with SHBG and increase the bioavailability of androgen."( Dietary Intake of 17α-Ethinylestradiol Promotes HCC Progression in Humanized Male Mice Expressing Sex Hormone-Binding Globulin.
Heo, JH; Hong, EJ; Jeong, SH; Jo, SL; Ko, JW; Kwun, HJ; Lee, SR, 2021
)
0.62
" Niosomes have been reported to improve the bioavailability of low water-soluble drugs."( The effectiveness of ursolic acid niosomes with chitosan coating for prevention of liver damage in mice induced by n-nitrosodiethylamine.
Cahyani, DM; Faradisa, AA; Hariawan, BS; Hendradi, E; Jauhari, AA; Miatmoko, A; Plumeriastuti, H; Sari, R, 2022
)
0.72
" However, its therapeutic activity is limited by poor bioavailability and unpredictable distribution."( Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a
El-Gizawy, SA; Essa, EA; Kira, AY; Nasr, M; Saber, S, 2023
)
0.91

Dosage Studied

A simple two-stage model of rat hepatocarcinogenesis was used. A single ip dose of diethylnitrosamine (DEN) as the initiator and sodium phenobarbitone or ethanol given in the drinking-water for 12-18 months was used to investigate dose-response relationships for initiation and promotion. Dose- response relationships indicated that island formation is due to a one-hit process.

ExcerptRelevanceReference
" DENA, which was administered to 38 rats in a dosage of 20 mg/kg/week, induced liver tumors in 90% of the animals; in 29% besides some precancerous stages predominantly malignant carcinomas of the oesophagus were seen."( Influence of disulfiram on the organotropy of the carcinogenic effect of dimethylnitrosamine and diethylnitrosamine in rats.
Diehl, B; Habs, M; Krüger, FW; Schmähl, D, 1976
)
0.47
"4 mg/kg body weight with a total dosage of 420 mg/kg over an experimental period of five years."( Hepatocarcinogenetic effect of DENA in pigs.
Berg, H; Graw, JJ, 1977
)
0.26
" The highest activity was obtained with antisera (Cx-1) produced by repeated intravenous injections of living L-10 cells at high cell dosage, whereas intramuscular injections of living or glutaraldehyde-treated L-10 cells at similar frequency and cell dosage were less effective for the production of cytotoxic antibodies against L-10 cells."( Susceptibility to and escape from complement-mediated lysis of guinea-pig hepatoma line-10.
Abe, S; Berczi, I; Sehon, AH, 1977
)
0.26
" This article deals with the methods that are presently applied for dose-response studies."( Problems of dose-response studies in chemical carcinogenesis with special reference to N-nitroso compounds.
Schmähl, D, 1979
)
0.26
"In mice given a single dose of diethylnitrosamine, a hepatonecrotic dose of carbon tetrachloride, 5 weeks after dosing with DEN and repeated 6 times at 4-weekly intervals, augmented the tumour yield in the livers."( Influence of repeated liver regeneration on hepatic carcinogenesis by diethylnitrosamine in mice.
McGuire, LJ; Poound, AW, 1978
)
0.78
" However, the hibernating females of the low dosage group developed fewer lung tumors."( Carcinogenicity of N-nitrosodiethylamine in hibernating and nonhibernating European hamsters.
Mohr, U; Reznik, G; Reznik-Schüller, R, 1977
)
0.26
" It was pointed out that the direct measurement of the dose-response relation (l(d) approximately dm) yields only the number of hits contributed by the carcinogen applied anose rate is low or very low, the contribution of background process becomes significant, and these hits contribute to the power of time, r, of the incidence-time relation."( Multi-hit kinetics of tumor formation, with special reference to experimental liver and human lung carcinogenesis and some gneral conclusions.
Emmelot, P; Scherer, E, 1977
)
0.26
" Cyclopentenone was dosed at a level of 18 ppm (seven hr/day, five days/week) during the first 52 weeks, and at a level of 27 ppm during the last 26 weeks of the study."( Repeated exposure to cyclopentenone vapour: long-term study in Syrian golden hamsters.
Feron, VJ; Kruysse, A, 1976
)
0.26
" DMN induced a considerable quantity of liver tumours, the highest incidence being demonstrated in the lowest dosage group."( Carcinogenic effects of different nitroso-compounds in Chinese hamsters. I. Dimethylnitrosamine and N-diethylnitrosamine.
Kmoch, N; Mohr, U; Reznik, G, 1976
)
0.47
"The dose-response of phenobarbital (PB) promotion of hepatocarcinogenesis in rats was investigated."( Threshold dose dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine.
Hayashi, Y; Maekawa, A; Matsushima, Y; Mitsumori, K; Ogasawara, H; Onodera, H, 1992
)
0.5
" At dosage levels equimolar to 500 ppm PB, none of the three compounds promoted development of hepatocellular adenomas or carcinomas, in contrast to PB."( Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat.
Diwan, BA; Henneman, JR; Lubet, RA; Nims, RW; Rice, JM; Ward, JM, 1992
)
0.28
" The data indicate that at least in hepatocellular tumours of the C57Bl/10J strain and using chronic dosing regimes the ras genes do not represent markers for in vivo genotoxic activity."( Point mutation analysis of ras genes in spontaneous and chemically induced C57Bl/10J mouse liver tumours.
Hardaker, KJ; Lord, PG; Loughlin, JM; Marsden, AM; Orton, TC, 1992
)
0.28
" The inhibitory effects of green tea infusion were also observed in a similar experiment using a higher dosage of NDEA (20 mg/kg)."( Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea.
Conney, AH; Hong, JY; Huang, MT; Reuhl, KR; Wang, ZY; Yang, CS, 1992
)
0.28
" A major uncertainty in risk assessment for TCDD is the lack of adequate dose-response relationships following chronic exposure to TCDD."( Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Clark, GC; Goldstein, JA; Lucier, GW; McCoy, Z; Portier, CJ; Tritscher, AM, 1992
)
0.28
"Groups of rats, either dosed with N-nitrosodiethylamine (NDEA) for 10 weeks (from the age of 7 to 17 weeks) or untreated, were fed diets containing either 2% (low fat, LF) or 30% polyunsaturated fat (high fat, HF) on an equicaloric basis from 5 weeks until rats were 43 weeks old."( Mechanisms of fat-related modulation of N-nitrosodiethylamine-induced tumors in rats: organ distribution, blood lipids, enzymes and pro-oxidant state.
Ahotupa, M; Bartsch, H; Béréziat, JC; Bussacchini-Griot, V; Cabral, JR; Camus, AM; Hietanen, E; Laitinen, M; Wild, H, 1991
)
0.28
" In order to show the usefulness of our assays, a preliminary study showing the ability of the immunobioassay to detect the expression of OFP in the plasma of carcinogen treated rats in a dosage dependent manner has been presented."( Development and use of monoclonal antibodies against an oncofetal protein associated with carcinogenesis and tumorigenesis.
Larroya-Runge, SN; Runge, SW; Schumm, DE; Webb, TE, 1991
)
0.28
" The principal aim was to characterize the dose-response relationship for the effects of these agents on esophageal cancer (NDEA) or on various types of liver cancer (NDEA and NDMA), although NDEA also caused a few tumors of the nasopharynx and NDMA also caused a few tumors of the lung."( Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study.
Brantom, P; Grasso, P; Gray, R; Peto, R, 1991
)
0.28
"One of the critical issues in risk assessment for chemical carcinogens is the evaluation of dose-response relationships for tumor promoters."( Dose-response relationships in promotion of rat hepatocarcinogenesis by 17 alpha-ethinylestradiol.
Campen, D; Lucier, G; Maronpot, R, 1990
)
0.28
" Four-day-old female F344/N rats were dosed with diethylnitrosamine (10 mg/kg)."( Effects of alpha-tocopherol, phenobarbital, and butylated hydroxyanisole during promotion of diethylnitrosamine-initiated rat hepatocarcinogenesis.
Duitsman, P; Hendrich, S; Jackson, A; Krueger, SK; Myers, RK, 1991
)
0.76
" A dose-response relationship of cell number reduction was observed at certain dose range."( [Effects of nitrosamine on in vitro cultured human esophageal epithelial cells].
Pei, XF, 1990
)
0.28
" Dose-response experiments showed that the hepatocarcinogenic effects of long-term chlordecone administration became undetectable at concentrations in non-initiated rat liver in the same range as those measured in human biopsies taken from exposed workers who exhibited no liver effects."( Evaluation of chlordecone in a two-stage model of hepatocarcinogenesis: a significant sex difference in the hepatocellular carcinoma incidence.
Blanke, RV; Fitzgerald, R; Guzelian, PS; Sirica, AE; Wilkerson, CS; Wu, LL, 1989
)
0.28
" The second step is evaluation of the independent dose-response relationships observed in animals and prediction of human risk distributions by normalizing time units with respect to species natural life span."( Scaling of fatal cancer risks from laboratory animals to man.
Raabe, OG, 1989
)
0.28
" The dose-response relationship was also determined in juvenile rats for a single and for up to 64 daily doses of 3 mg/kg DENA started on day 32 of age."( The effect of single versus split doses of diethylnitrosamine on the induction of gamma-glutamyltranspeptidase-foci in the livers of adult and juvenile rats.
Herren-Freund, SL; Khoury, MM; Long, RE; Pereira, MA, 1986
)
0.53
"Using the rat liver foci bioassay a dose-response relationship was evaluated for the promoting activity of the ubiquitous and persistent environmental pollutants polychlorinated biphenyls (PCBs) and chloroform."( Dose-response of promotion by polychlorinated biphenyls and chloroform in rat liver foci bioassay.
Deml, E; Oesterle, D, 1987
)
0.27
" Similar dose-response data were obtained at various doses of two promoting agents effective in hepatocarcinogenesis, PB and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), in livers of F-344 female rats following initiation with DEN (10 mg/kg) 24 h post-70% hepatectomy."( A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.
Campbell, HA; Glauert, HP; Goldsworthy, TL; Kennan, W; Maronpot, RR; Moran, S; Pitot, HC, 1987
)
0.27
" Therefore, we have begun to quantify the dose-response relationships for N-nitrosodiethylamine (NDEA)-induced hepatocarcinogenesis by characterizing the major promutagenic DNA adduct, O4-ethyldeoxythymidine (O4-etdT); hepatocyte proliferation; and hepatocyte initiation in rats continually exposed to drinking-water containing NDEA."( Molecular dosimetry of DNA alkylation during chronic exposure to carcinogens.
Boucheron, JA; Deal, FH; Richardson, FC; Swenberg, JA; Tyeryar, LA, 1987
)
0.27
" For extrapolation of test results from animals to humans, knowledge of the carcinogenic potency, the dose-response relationship, and the toxicokinetic behavior of the test chemical is essential."( Predictability of human carcinogenicity from animal studies.
Dybing, E, 1986
)
0.27
" Putative preneoplastic lesions in the liver were first observed according to the substance and dosage applied as follows: DENA 1 X weekly (group II), beginning on day 258; DENA 2 X weekly (group III), beginning on day 183; and CC + DENA 2 X weekly (group V), beginning on day 231."( Histology and histochemistry of the liver of chickens after DENA induced hepatocarcinogenesis and ingestion of low chlorinated biphenyls.
Brunn, H; Eigenbrodt, E; Manz, D; Reinacher, M; Schmidt, E, 1987
)
0.27
"We have investigated levels of transcript homologous with glutathione S-transferase P (GST-P; GST 7-7) in tumours and hyperplastic lesions induced in the livers of rats by long-term gavage dosing with diethylnitrosamine (DEN) and 6-p-dimethylaminophenylazobenzothiazole (6BT)."( Long-term dosing studies using mutagenic carcinogens indicate a highly significant correlation between elevations in the level of rat glutathione S-transferase P messenger RNA and liver tumours of hepatocellular origin.
Humphries, P; Kelly, M; McQuaid, S; Pearson, C; Russell, SE, 1988
)
0.46
"The dose-response of diethylnitrosamine (DENA) initiation of hepatocarcinogenesis was determined in infant Balb/c male mice with and without subsequent phenobarbital treatment."( Dose-response relationship of diethylnitrosamine-initiated tumors in neonatal balb/c mice: effect of phenobarbital promotion.
Klaunig, JE; Pereira, MA; Ruch, RJ; Weghorst, CM, 1988
)
0.88
" The analysis of dose-response data showed first order kinetics (single event) regarding the induction of intermediate basophilic foci (IBF) and hepatocellular carcinomas (HCC)."( Certain aspects of hepatocarcinogenesis in the infant mouse model.
Vesselinovitch, SD, 1987
)
0.27
"The dose-response relationship was determined in rats for the enhancement by phenobarbital of diethylnitrosamine (DENA)-initiated neoplastic nodules and hepatocellular carcinomas."( Dose-response relationship of phenobarbital promotion of diethylnitrosamine initiated tumors in rat liver.
Herren-Freund, SL; Long, RE; Pereira, MA, 1986
)
0.74
" In subchronic studies, PB was administered in drinking water to 5-week-old male hamsters for periods of 8 or 16 weeks at dosage levels of 250, 500, or 1000 ppm."( Lack of effect of phenobarbital on hepatocellular carcinogenesis initiated by N-nitrosodiethylamine or methylazoxymethanol acetate in male Syrian golden hamsters.
Anderson, LM; Diwan, BA; Hagiwara, A; Rice, JM; Ward, JM, 1986
)
0.27
" A simple two-stage model of rat hepatocarcinogenesis with a single ip dose of diethylnitrosamine (DEN) as the initiator and sodium phenobarbitone or ethanol given in the drinking-water for 12-18 months as the promoter was used to investigate dose-response relationships for initiation and promotion."( Dose-response relationships for initiation of rat liver tumours by diethylnitrosamine and promotion by phenobarbitone or alcohol.
Driver, HE; McLean, AE, 1986
)
0.73
") at 4 weeks of age with N-nitrosodiethylamine (DEN) at a dosage of 80 mg/kg."( Di(2-ethylhexyl)phthalate but not phenobarbital promotes N-nitrosodiethylamine-initiated hepatocellular proliferative lesions after short-term exposure in male B6C3F1 mice.
Lynch, P; Ohshima, M; Riggs, C; Ward, JM, 1984
)
0.27
"A dose-response study of the carcinogenicity of N-nitrosodiethanolamine was conducted in F344 rats."( Dose-response study with N-nitrosodiethanolamine in F344 rats.
Lijinsky, W; Reuber, MD, 1984
)
0.27
"Using the Solt and Farber model (Nature, 263 (1976) 701), dose-response relationships between initiating agents and the induction of hyperplastic nodules in rat liver were investigated."( Dose responses of five hepatocarcinogens for the initiation of rat hepatocarcinogenesis.
Imaida, K; Ito, N; Shirai, T; Takano, T; Tatematsu, M, 1981
)
0.26
" Damage was monitored in vivo by the alkaline elution method, in which DNA is dosed fluorometrically."( Evaluation of DNA damage by the alkaline elution technique in liver, kidneys and lungs of rats and hamsters treated with N-nitrosodialkylamines.
Barbin, A; Bartsch, H; Béréziat, JC, 1983
)
0.27
" The dose-response relationship, transformation probabilities, and the dose versus time to 50% incidence of the early (basophilic foci) and later appearing focal and nodular hepatocellular lesions were evaluated."( Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse.
Mihailovich, N; Vesselinovitch, SD, 1983
)
0.64
" After topical application NDELA was slowly absorbed percutaneously, but once absorbed was distributed as in the orally dosed rats."( The fate of N-nitrosodiethanolamine after oral and topical administration to rats.
Brouwer, E; Lethco, EJ; Wallace, WC, 1982
)
0.26
" The clearing method was used successfully to discern differences in tumor incidence in a dose-response study with diethylnitrosamine."( A method for rapid scoring of respiratory tumors in hamsters.
Dalbey, WE, 1980
)
0.47
" Positive results were obtained from the 15th day of gestation and a linear dose-response relationship is expressed when micronucleated polychromatic erythrocytes are measured in neonatal blood, after transplacental exposure late in gestation."( Short-term tests for transplacentally active carcinogens: sensitivity of the transplacental micronueleus test to diethylnitrosamine.
Arlett, CF; Cole, J; Cole, RJ; Henderson, L; Taylor, N, 1982
)
0.48
"A dose-response study was conducted in Fischer rats with nitrosodiethylamine, which was administered in regulated amounts as a solution in drinking water."( Dose response studies of carcinogenesis in rats by nitrosodiethylamine.
Lijinsky, W; Reuber, MD; Riggs, CW, 1981
)
0.26
" It was also shown that a discontinuous dosage of disulfiram protects against the alkylating effect of 14C nitrosodiethylamine only for a distinct period of time."( Effect of disulfiram on the alkylation of rat liver DNA by nitrosodiethylamine.
Bertram, B; Frank, N; Hadjiolov, D; Wiessler, M, 1980
)
0.26
"A CK immunohistochemical study was carried out on histologic sections from hepatocellular carcinomas (HCCs) and preneoplastic lesions from 118 monkeys chronically dosed with diethylnitrosamine (DEN), using mAbs to CK 8, CK 18, CK 7, and CK 19."( Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Bocsi, J; Lapis, K; Sarosi, I; Thorgeirsson, UP, 1995
)
0.74
"8-fold increased over controls in the TCDD group with waiting period compared to a 4-fold increase over controls at the end of the 30 week dosing period."( Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
Clark, GC; Lucier, GW; Maronpot, R; Sewall, C; Sills, RC; Tritscher, AM, 1995
)
0.29
" No elevation above control values could be proved after having dosed the rats with N-nitrosamines."( N-nitrosodimethylamine, N-nitrosodiethylamine, and N-nitrosomorpholine fail to generate 8-hydroxy-2'-deoxyguanosine in liver DNA of male F344 rats.
Appel, KE; Dahlhaus, M, 1993
)
0.29
"We investigated the role of dosing regimen on ras mutations in chemically induced CD-1 mouse liver tumors."( Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors.
Hammermeister, CL; Joslyn, DJ; Kraynak, AR; Leander, KR; Ledwith, BJ; Manam, S; Nichols, WW; Prahalada, S; Shinder, GA; van Zwieten, MJ, 1995
)
0.29
" The slope of the dose-response curve was rather steep."( Dose dependence of diethylnitrosamine-induced nuclear enlargement in embryonal turkey liver.
Bannasch, P; Enzmann, H; Kühlem, C; Löser, E, 1995
)
0.62
" Multiplicities decreased in the order Ar-1254 > PB > DDT, indicating that Ar-1254 was more potent than either PB or DDT at the dosage levels used."( Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitrosodiethylamine and subsequently given Aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarb
Diwan, BA; Kurata, Y; Rice, JM; Ward, JM,
)
0.13
" In contrast, the dose-response curve observed for DEN-treated rats 18 weeks after carcinogen administration was similar to that observed 2 weeks after carcinogen treatment for both phenobarbital- and non-phenobarbital-treated rats."( Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats.
Baker, K; Campbell, HA; Dragan, YP; Mass, M; Pitot, HC; Vaughan, J, 1994
)
0.29
" The dose-response curve for fish maintained an additional 6 months postexposure was shifted toward higher incidence but was parallel to the curve for fish killed at cessation of exposure."( Dose-dependent carcinogenicity and frequent Ki-ras proto-oncogene activation by dietary N-nitrosodiethylamine in rainbow trout.
Bailey, GS; Cheng, R; Hendricks, JD; Pereira, CB; Shelton, DW, 1994
)
0.29
"The dose-response characteristics of initiation of hepatocarcinogenesis by diethylnitrosamine (DEN) was investigated in the neonatal female rat by means of the quantitative stereologic estimation of altered hepatic foci (AHF) expressing multiple markers."( The effect of the dose of diethylnitrosamine on the initiation of altered hepatic foci in neonatal female rats.
Dragan, YP; Pitot, HC; Xu, YH, 1993
)
0.82
"The present study examines the dose-response relationship for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) promotion of histologic and biochemical parameters by using a two-stage model for hepatocarcinogenesis in female Sprague-Dawley rats initiated with a single intraperitoneal dose of 175 mg of diethylnitrosamine (DEN)/kg body weight at 70 days of age."( Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints.
Clark, G; Foley, JF; Goldsworthy, T; Lucier, G; Maronpot, RR; Portier, C; Takahashi, K; Tritscher, A, 1993
)
0.46
" We report here that the bioassay can rapidly detect carcinogenic doses of HCB and that there is a clear dose-response relationship."( Medium-term bioassay for the hepatocarcinogenicity of hexachlorobenzene.
Cabral, R; Hakoi, K; Hasegawa, R; Hoshiya, T; Ito, N, 1996
)
0.29
" In the present study we examined the dose-response effect of dieldrin (at several doses) on focal lesion growth (tumor promotion), hepatocyte apoptosis and DNA synthesis in rat and mouse liver."( Selective dieldrin promotion of hepatic focal lesions in mice.
Klaunig, JE; Kolaja, KL; Stevenson, DE; Walborg, EF, 1996
)
0.29
" Because the dose-response curves were considered non-linear for most nitrosamines, synergistic effects were not apparent for the 1/4 mixture."( Effects of low dose mixtures of four N-nitroso compounds on hepatic foci development in the rat.
Futakuchi, M; Hasegawa, R; Hirose, M; Ito, N; Lijinsky, W; Shirai, T, 1996
)
0.29
"1 ppm range, the dose-response for esophageal tumor formation was sublinear, possibly due to DNA repair."( N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation.
Verna, L; Whysner, J; Williams, GM, 1996
)
0.29
"The dose-response relationship between liver tumor promoting activity and cytochrome P-450 (CYP) induction by phenobarbital sodium (PB) was investigated using the liver medium-term bioassay system of Ito."( Dose-related increases in quantitative values for altered hepatocytic foci and cytochrome P-450 levels in the livers of rats exposed to phenobarbital in a medium-term bioassay.
Fukushima, S; Funae, Y; Hagiwara, A; Imaoka, S; Kitano, M; Matsuda, T; Shirai, T; Takesada, Y; Tamano, S, 1996
)
0.29
" Female Sprague-Dawley rats were dosed with diethylnitrosamine (15 mg/kg) at 24 h of age."( Effect of dietary lipid on gamma-glutamyl transferase-positive foci during hepatocarcinogenesis in rats.
Chen, HW; Ko, JJ; Lii, CK, 1998
)
0.56
"Determining both the mechanism by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) acts as a tumor promoter and the shape of the dose-response curve at low doses remains an important goal of risk-assessment-directed research."( Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
Dragan, YP; Goldsworthy, T; Pitot, HC; Singh, J; Teeguarden, JG; Vaughan, J; Xu, YH, 1999
)
0.3
" Three weeks after DEN treatment, Fas-mediated liver cell apoptosis induced by anti-Fas antibody resulted in a biphasic effect on induction of liver cell tumours, depending on dosage and time of antibody administration."( Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice.
Hara, A; Kawabata, K; Matsunaga, K; Mori, H; Sugie, S; Yamada, Y; Yoshimi, N, 2000
)
0.56
" Blood levels of DEA reflected the dosing method used; oral greater than dermal with access greater than dermal without access."( Potential mechanisms of tumorigenic action of diethanolamine in mice.
Bartels, MJ; Brzak, KA; Mar, M; Markham, DA; Stott, WT; Thornton, CM; Zeisel, SH, 2000
)
0.31
" This research confirms the effectiveness of the DEN in bringing about carcinogenesis in the Wistar rat esophagus and also shows that the lesions are dosage dependent."( Experimental esophageal carcinogenesis: technical standardization and results.
Andreollo, NA; Eshkenazy, R; Pajecki, D; Sallet, JA; Zilberstein, B, 2002
)
0.31
" The chemicals were found to differ characteristically in their potency and dose-response relationship to induce FAH when given alone or when administered following initiation with diethylnitrosamine."( Prevalidation of a rat liver foci bioassay (RLFB) based on results from 1600 rats: a study report.
Bannasch, P; Brendler-Schwaab, S; Deml, E; Enzmann, H; Haertel, T; Ittrich, C; Kopp-Schneider, A; Küttler, K; Mellert, W; Mönnikes, O; Oesterle, D; Schladt, L; Schwarz, M,
)
0.32
" However, they were unable to predict the shape of the dose-response curve at low doses."( Threshold for carcinogenicity of N-nitrosodiethylamine for esophageal tumors in rats.
Waddell, WJ, 2003
)
0.32
"An underlying basis of risk assessment is that an equivalent risk for a specified dose metric exists that allows for extrapolation of dose-response relationships between species."( Area under the curve as a dose metric for promotional responses following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure.
Kim, AH; Kohn, MC; Nyska, A; Walker, NJ, 2003
)
0.32
" A dose-response relationship for induction of abnormal nuclei was observed."( Detection by dual color fluorescence in situ hybridization of in vivo chromosome damage in rat hepatocyte nuclei.
Matsumoto, K, 2003
)
0.32
" Resveratrol feeding caused a significant reduction in microsomal cyclooxygenase (COX) activities in the liver and lungs, while the dosage of NDEA (200 mg/kg body weight) induced COX activity 24 h after its administration."( Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice.
Bhardwaj, A; Kaushik, G; Khanduja, KL, 2004
)
0.32
" PB produced a twofold increase in liver MF over controls after 27 weeks of treatment, but a similar increase was not observed with longer dosing times; at later time points, the MF in the PB groups was lower than that of the control group, suggesting that PB is not producing direct DNA damage in the liver."( Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
de Boer, J; Fairchild, D; Glickman, B; Johnson, A; Kanazawa, N; Mirsalis, JC; Nguyen, T; Shimon, JA; Winegar, RA, 2005
)
0.33
" No NDELA was formed in rats repeatedly dermally dosed with TEA at the limits of detection in blood (0."( Investigation of the formation of N-nitrosodiethanolamine in B6C3F1 mice following topical administration of triethanolamine.
Bartels, MJ; Brzak, KA; Markham, DA; Saghir, SA; Stott, WT, 2005
)
0.33
"Comparisons on a linear and the Rozman logarithmic scale for dosage versus carcinogenicity in rodents are presented for methyl eugenol (ME), nitrosodiethylamine (NDEA), ethyl carbamate (EC) and 2-acetylaminofluorene (AAF)."( Comparisons of thresholds for carcinogenicity on linear and logarithmic dosage scales.
Waddell, WJ, 2005
)
0.33
"05 ppm, caused significant reduction, showing a J-shape dose-response curve."( Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes.
Fukushima, S; Funae, Y; Kinoshita, A; Mitsuru, F; Morimura, K; Oka, M; Puatanachokchai, R; Wanibuchi, H; Yamaguchi, S, 2006
)
0.33
" Two reports recorded the appearance of tumors after treatment with NDEA, although one used a different dosing schedule that included phenobarbital promotion."( Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
Fukushima, S; Waddell, WJ; Williams, GM, 2006
)
0.33
" The better correlation between 8-oxodG formation and tumor response indicates that dose-response information from the female rat would be much more relevant to human risk assessment."( Etiology of bromate-induced cancer and possible modes of action-studies in Japan.
Kurokawa, Y; Umemura, T, 2006
)
0.33
" Examples are shown, illustrating that the current practice of labeling dose-response curves for carcinogenesis as supralinear, linear or sublinear, is meaningless unless the dose-response scales are defined."( Critique of dose response in carcinogenesis.
Waddell, WJ, 2006
)
0.33
"5 ppm vanadium is potentially and optimally effective, as derived from dose-response studies, in limiting early molecular events and preneoplastic lesions, thereby modulating the initiation stage of hepatocarcinogenesis."( Carcinogen-induced early molecular events and its implication in the initiation of chemical hepatocarcinogenesis in rats: chemopreventive role of vanadium on this process.
Chakraborty, T; Chatterjee, A; Chatterjee, M; Dhachinamoorthi, D; Kumar P, A; Rana, A, 2007
)
0.34
"Within the scope of the Rat Liver Foci Bioassay the model carcinogens N-nitrosomorpholine (NNM), 2-acetylaminoflouren (2-AAF), phenobarbital (PB), and clofibrate (CF) were analyzed concerning their potency and dose-response relationship to induce foci of altered hepatocytes (FAHs), which are known to be precursor lesions of liver adenoma and carcinoma."( Comparison of mode of action of four hepatocarcinogens: a model-based approach.
Bannasch, P; Groos, J; Kopp-Schneider, A; Schwarz, M, 2007
)
0.34
" Simultaneously, hepatocarcinoma were induced in groups II-V by diethylnitrosamine (DEN) solution (100 mg/L) at the dosage of 10 mg/kg body weight every day as drinking water for 16 weeks, then sterilized water for a further two weeks."( Effect of selenium-enriched malt on hypoglycemia and regulatory hormones in diethylnitrosamine-induced hepatocarcinoma SD rats.
Liu, JG; Liu, YJ; Wang, XL; Zhao, HJ, 2009
)
0.82
" Using this model, we investigated the efficacy of an equivalent dosage of dietary LY from either a pure compound or a tomato extract (TE) against NASH-promoted hepatocarcinogenesis."( Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats.
Ausman, LM; Greenberg, AS; Russell, RM; Wang, XD; Wang, Y, 2010
)
0.36
"Recent studies have demonstrated that frequent, low-dose metronomic (MET) dosing of cytotoxic agents may not only be as efficient as conventional maximum tolerated dose (MTD) chemotherapy but also less toxic."( Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis.
Bae, SH; Choi, JY; Hur, W; Jang, JW; Kim, GD; Kim, JD; Kwon, JH; Park, JA; Park, ST; Woo, HY; Yoo, CR; Yoon, SK, 2010
)
0.36
"As susceptibility to carcinogens varies considerably among different strains of experimental animals, evaluation of dose-response relationships for genotoxic carcinogen in different strains is indispensable for risk assessment."( Potassium bromate enhances N-ethyl-N-hydroxyethylnitrosamine-induced kidney carcinogenesis only at high doses in Wistar rats: indication of the existence of an enhancement threshold.
Doi, K; Fukushima, S; Hamoud, AS; Kakehashi, A; Kitano, M; Kushida, M; Morimura, K; Wanibuchi, H; Wei, M; Yamaguchi, T, 2009
)
0.35
" To induce hepatocarcinoma, groups II-V rats received diethylnitrosamine solution (100mg/L) at the dosage of 10mg/kg body weight in drinking water daily for 16 weeks, followed by sterilized water for a further 2 weeks."( Effect of selenium-enriched malt on VEGF and several relevant angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
Liu, JG; Liu, YJ; Wang, XL; Zhao, HJ, 2010
)
0.83
" The level of hepatic microsomal lipid peroxidation, expressed as thiobarbituric acid reactive substances (TBARS), was increased in animals dosed with NDEA and CCl(4)."( Protective effect of chokeberry on chemical-induced oxidative stress in rat.
Ewertowska, M; Ignatowicz, E; Jodynis-Liebert, J; Kujawska, M; Oszmiański, J, 2011
)
0.37
" At day 0, the fertilized eggs of the dosed groups were injected with 1 (LD) or 4 (HD) mg/egg (about 12."( Production of liver preneoplasia and gallbladder agenesis in turkey fetuses administered diethylnitrosamine.
Brunnemann, KD; Enzmann, HG; Iatropoulos, MJ; Smart, DJ; Williams, GM, 2011
)
0.59
" These results provide a rationale for long-term MET dosing in future clinical trials of HCC treatment."( Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma.
Bae, SH; Choi, JY; Jang, JW; Jung, CK; Kwon, JH; Park, ST; Yoon, SK; You, CR, 2011
)
0.37
" In the present study, the authors treated C57BL/6 mice with 25, 50, and 75 mg/kg of diethylnitrosamine (DEN) for 4 or 8 weeks by intraperitoneal injection to investigate the dose-response pattern of preneoplastic and neoplastic lesion formation in the liver."( Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice.
Kamendulis, LM; Klaunig, JE; Kushida, M; Peat, TJ, 2011
)
0.84
" indica leaf extract (AAILE) was administered orally at a dosage of 100 μg/g body weight thrice a week till termination of the study."( Azadirachta indica exhibits chemopreventive action against hepatic cancer: Studies on associated histopathological and ultrastructural changes.
Bharati, S; Koul, A; Rishi, P, 2012
)
0.38
" The chromosomal aberration evaluation revealed a discrete dose-response curve."( N-nitrosodiethylamine genotoxicity evaluation: a cytochrome P450 induction study in rat hepatocytes.
Aiub, CA; Eckl, P; Felzenszwalb, I; Ferreira, F; Gadermaier, G; Pinto, LF; Silva, IO, 2011
)
0.37
"This experiment was designed to compare the effect of two selenium sources at the dosage of therapeutic level on hepatocarcinogenesis and angiogenic cytokines in DEN-induced hepatocarcinoma rats to further approach their possible anticancer's mechanism."( Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
Liu, JG; Liu, YJ; Liu, YW; Wang, XL; Zhao, HJ, 2012
)
0.6
" We have already reported that dosing of the test compound after partial hepatectomy (PH) is essential to detect genotoxicity of numerical chromosome aberration inducers in mice [Mutat."( Structural and numerical chromosome aberration inducers in liver micronucleus test in rats with partial hepatectomy.
Hattori, C; Itoh, S; Nagata, M; Sanbuissho, A, 2012
)
0.38
" In Experiment 2, the same experiment as Experiment 1 was performed, but the dosage of OPZ was 0 or 276 mg/kg."( Liver tumor promoting effect of omeprazole in rats and its possible mechanism of action.
Hayashi, H; Ishii, Y; Mitsumori, K; Morita, R; Shibutani, M; Shimamoto, K; Suzuki, K; Taniai, E, 2012
)
0.38
" indica leaf extract (AAILE) was administered orally at a dosage of 100 μg/g body mass till the termination of experiment."( Azadirachta indica modulates electrical properties and type of cell death in NDEA-induced hepatic tumors.
Bharati, S; Koul, A; Rishi, P, 2014
)
0.4
" In the present study, we assessed a twice dosing regimen, in which the genotoxicant is dosed both before and after partial hepatectomy, using the four chromosome aberration inducers used in the previous study."( Assessment of a twice dosing regimen both before and after partial hepatectomy in the rat liver micronucleus test.
Hattori, C; Igarashi, M; Itoh, S; Nagata, M, 2015
)
0.42
" The most appropriate approach to use in low dose-response assessment must be approved on the basis of scientific judgment."( Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
Fukushima, S; Gi, M; Kakehashi, A; Matsumoto, M; Wanibuchi, H, 2016
)
0.43
" In this assay, accumulation of micronucleated hepatocytes (MNHEPs) induced by repeated dosing of genotoxic chemicals is considered to be a key factor in the detection of micronuclei induction."( Prolonged rest period enables the detection of micronucleated hepatocytes in the liver of young adult rats after a single dose of diethylnitrosamine or mitomycin C.
Miyamae, Y; Seki, J; Shimada, K; Takashima, M; Wakata, A; Yamamoto, M, 2015
)
0.62
" The experiment was terminated after the 24 h of last dosage of Fe-NTA, and all the animals were sacrificed."( Nephroprotective effect of β-sitosterol on N-diethylnitrosamine initiated and ferric nitrilotriacetate promoted acute nephrotoxicity in Wistar rats.
Arockianathan, PM; Sharmila, R; Sindhu, G, 2016
)
0.69
" Clinically achievable dosing of EGCG was well-tolerated in diethylnitrosamine-injured rats and was associated with improved serum liver markers including alanine transaminase, aspartate transaminase, and total bilirubin, and reduced HCC tumor formation."( Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
Erstad, DJ; Fuchs, BC; Fujii, T; Hirschfield, H; Hoshida, Y; Kim, RS; Lanuti, M; Lauwers, GY; Sojoodi, M; Tanabe, KK; Wei, L; Yamada, S, 2020
)
0.8
" The non-toxic dosage of eugenol was shown to enhance apoptosis, simultaneously suppressing cell proliferation in the lung tissue of carcinogen-treated mice without affecting the normal mice."( Eugenol emerges as an elixir by targeting β-catenin, the central cancer stem cell regulator in lung carcinogenesis: an
Barua, A; Bhattacharyya, M; Choudhury, P; Pattanayak, R; Roy, A; Saha, P, 2021
)
0.62
"ADI can inhibit a lot of CYP450 enzyme, so it may reduce the dosage of chemotherapeutic drugs to reach the required plasma concentration of chemotherapeutic drugs, which is of great significance for the combination of anti-tumor chemotherapeutic drugs and is worthy of further in-depth study and clinical attention."( Aidi injection altered the activity of CYP2D4, CYP1A2, CYP2C19, CYP3A2, CYP2E1 and CYP2C11 in normal and diethylnitrosamine-induced hepatocellular carcinoma in rats.
He, Y; Huang, Y; Jin, Y; Li, Y; Liu, W; Lu, Y; Pan, J; Wang, Y; Zheng, L, 2022
)
0.94
"N-Nitrosodiethylamine (NDEA), a well-studied N-nitrosamine, was tested in rats to compare the dose-response relationship of three genotoxicity endpoints."( Comparison of the transgenic rodent mutation assay, error corrected next generation duplex sequencing, and the alkaline comet assay to detect dose-related mutations following exposure to N-nitrosodiethylamine.
Bercu, JP; Escobar, PA; Schuler, M; Sobol, Z; Van, P; Zhang, S, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
hepatotoxic agentA role played by a chemical compound exihibiting itself through the ability to induce damage to the liver in animals.
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
nitrosamineN-Nitroso amines, compounds of the structure R2NNO. Compounds RNHNO are not ordinarily isolable, but they, too, are nitrosamines. The name is a contraction of N-nitrosoamine and, as such, does not require the N locant.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency27.41710.000714.592883.7951AID1259369
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.05010.001318.074339.8107AID926; AID938
retinoid X nuclear receptor alphaHomo sapiens (human)Potency23.55390.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency12.05170.001530.607315,848.9004AID1224841; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency39.97530.000229.305416,493.5996AID743075; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.05620.001024.504861.6448AID588535
aryl hydrocarbon receptorHomo sapiens (human)Potency68.86870.000723.06741,258.9301AID743085
activating transcription factor 6Homo sapiens (human)Potency61.64480.143427.612159.8106AID1159516
chromobox protein homolog 1Homo sapiens (human)Potency79.43280.006026.168889.1251AID540317
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.02510.010039.53711,122.0200AID588547
gemininHomo sapiens (human)Potency0.07310.004611.374133.4983AID624297
lethal factor (plasmid)Bacillus anthracis str. A2012Potency25.11890.020010.786931.6228AID912
Nuclear receptor ROR-gammaHomo sapiens (human)Potency16.78550.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID226732The compound was modelled in silico for carcinogenic potency; + = Carcinogen1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer-assisted studies of structure-activity relationships of N-nitroso compounds using pattern recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3,413)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901152 (33.75)18.7374
1990's760 (22.27)18.2507
2000's545 (15.97)29.6817
2010's758 (22.21)24.3611
2020's198 (5.80)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.85 (24.57)
Research Supply Index8.19 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index52.86 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.03%)5.53%
Reviews56 (1.55%)6.00%
Case Studies2 (0.06%)4.05%
Observational0 (0.00%)0.25%
Other3,555 (98.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]